Amantadine May Optimize Levodopa Regimen in Parkinson Disease Treatment

Amantadine May Optimize Levodopa Regimen in Parkinson Disease Treatment
The following article is part of conference coverage from the 2019 American Academy of Neurology Annual Meeting (AAN 2019) in Philadelphia, PA. Neurology Advisor’s staff will be reporting breaking news associated with research conducted by leading experts in neurology. Check back for the latest news from AAN 2019. PHILADELPHIA, PA — Long-term adjunctive amantadine (Gocovri®, Adamas Pharmaceuticals) treatment ... read more
Source: Neurology AdvisorPublished on 2019-05-08By Nicole Clemons